537 related articles for article (PubMed ID: 26331942)
1. TOLLIP, MUC5B, and the Response to N-Acetylcysteine among Individuals with Idiopathic Pulmonary Fibrosis.
Oldham JM; Ma SF; Martinez FJ; Anstrom KJ; Raghu G; Schwartz DA; Valenzi E; Witt L; Lee C; Vij R; Huang Y; Strek ME; Noth I;
Am J Respir Crit Care Med; 2015 Dec; 192(12):1475-82. PubMed ID: 26331942
[TBL] [Abstract][Full Text] [Related]
2. Potential clinical utility of MUC5B und TOLLIP single nucleotide polymorphisms (SNPs) in the management of patients with IPF.
Bonella F; Campo I; Zorzetto M; Boerner E; Ohshimo S; Theegarten D; Taube C; Costabel U
Orphanet J Rare Dis; 2021 Feb; 16(1):111. PubMed ID: 33639995
[TBL] [Abstract][Full Text] [Related]
3. Genetic variants associated with idiopathic pulmonary fibrosis susceptibility and mortality: a genome-wide association study.
Noth I; Zhang Y; Ma SF; Flores C; Barber M; Huang Y; Broderick SM; Wade MS; Hysi P; Scuirba J; Richards TJ; Juan-Guardela BM; Vij R; Han MK; Martinez FJ; Kossen K; Seiwert SD; Christie JD; Nicolae D; Kaminski N; Garcia JGN
Lancet Respir Med; 2013 Jun; 1(4):309-317. PubMed ID: 24429156
[TBL] [Abstract][Full Text] [Related]
4. Design and rationale for the prospective treatment efficacy in IPF using genotype for NAC selection (PRECISIONS) clinical trial.
Podolanczuk AJ; Kim JS; Cooper CB; Lasky JA; Murray S; Oldham JM; Raghu G; Flaherty KR; Spino C; Noth I; Martinez FJ;
BMC Pulm Med; 2022 Dec; 22(1):475. PubMed ID: 36514019
[TBL] [Abstract][Full Text] [Related]
5. Predictive value of common genetic variants in idiopathic pulmonary fibrosis survival.
Mota PC; Soares ML; Vasconcelos CD; Ferreira AC; Lima BA; Manduchi E; Moore JH; Melo N; Novais-Bastos H; Pereira JM; Guimarães S; Moura CS; Marques JA; Morais A
J Mol Med (Berl); 2022 Sep; 100(9):1341-1353. PubMed ID: 35986225
[TBL] [Abstract][Full Text] [Related]
6. Prognostic role of MUC5B rs35705950 genotype in patients with idiopathic pulmonary fibrosis (IPF) on antifibrotic treatment.
Biondini D; Cocconcelli E; Bernardinello N; Lorenzoni G; Rigobello C; Lococo S; Castelli G; Baraldo S; Cosio MG; Gregori D; Saetta M; Balestro E; Spagnolo P
Respir Res; 2021 Apr; 22(1):98. PubMed ID: 33794872
[TBL] [Abstract][Full Text] [Related]
7. The MUC5B promoter polymorphism and telomere length in patients with chronic hypersensitivity pneumonitis: an observational cohort-control study.
Ley B; Newton CA; Arnould I; Elicker BM; Henry TS; Vittinghoff E; Golden JA; Jones KD; Batra K; Torrealba J; Garcia CK; Wolters PJ
Lancet Respir Med; 2017 Aug; 5(8):639-647. PubMed ID: 28648751
[TBL] [Abstract][Full Text] [Related]
8. Association between the MUC5B promoter polymorphism and survival in patients with idiopathic pulmonary fibrosis.
Peljto AL; Zhang Y; Fingerlin TE; Ma SF; Garcia JG; Richards TJ; Silveira LJ; Lindell KO; Steele MP; Loyd JE; Gibson KF; Seibold MA; Brown KK; Talbert JL; Markin C; Kossen K; Seiwert SD; Murphy E; Noth I; Schwarz MI; Kaminski N; Schwartz DA
JAMA; 2013 Jun; 309(21):2232-9. PubMed ID: 23695349
[TBL] [Abstract][Full Text] [Related]
9. The MUC5B promoter polymorphism is associated with idiopathic pulmonary fibrosis in a Mexican cohort but is rare among Asian ancestries.
Peljto AL; Selman M; Kim DS; Murphy E; Tucker L; Pardo A; Lee JS; Ji W; Schwarz MI; Yang IV; Schwartz DA; Fingerlin TE
Chest; 2015 Feb; 147(2):460-464. PubMed ID: 25275363
[TBL] [Abstract][Full Text] [Related]
10. Association between MUC5B polymorphism and susceptibility and severity of idiopathic pulmonary fibrosis.
Jiang H; Hu Y; Shang L; Li Y; Yang L; Chen Y
Int J Clin Exp Pathol; 2015; 8(11):14953-8. PubMed ID: 26823827
[TBL] [Abstract][Full Text] [Related]
11. Telomere Length and Use of Immunosuppressive Medications in Idiopathic Pulmonary Fibrosis.
Newton CA; Zhang D; Oldham JM; Kozlitina J; Ma SF; Martinez FJ; Raghu G; Noth I; Garcia CK
Am J Respir Crit Care Med; 2019 Aug; 200(3):336-347. PubMed ID: 30566847
[No Abstract] [Full Text] [Related]
12. N-acetylcysteine exposure is associated with improved survival in anti-nuclear antibody seropositive patients with usual interstitial pneumonia.
Oldham JM; Witt LJ; Adegunsoye A; Chung JH; Lee C; Hsu S; Chen LW; Husain A; Montner S; Vij R; Strek ME; Noth I
BMC Pulm Med; 2018 Feb; 18(1):30. PubMed ID: 29422061
[TBL] [Abstract][Full Text] [Related]
13. Shared genetic etiology between idiopathic pulmonary fibrosis and COVID-19 severity.
Fadista J; Kraven LM; Karjalainen J; Andrews SJ; Geller F; ; Baillie JK; Wain LV; Jenkins RG; Feenstra B
EBioMedicine; 2021 Mar; 65():103277. PubMed ID: 33714028
[TBL] [Abstract][Full Text] [Related]
14. MUC5B rs35705950 minor allele associates with older age and better survival in idiopathic pulmonary fibrosis.
van der Vis JJ; Prasse A; Renzoni EA; Stock CJW; Caliskan C; Maher TM; Bonella F; Borie R; Crestani B; Petrek M; Wuyts WA; Wind AE; Molyneaux PL; Grutters JC; van Moorsel CHM
Respirology; 2023 May; 28(5):455-464. PubMed ID: 36571111
[TBL] [Abstract][Full Text] [Related]
15. Analysis of protein-altering variants in telomerase genes and their association with MUC5B common variant status in patients with idiopathic pulmonary fibrosis: a candidate gene sequencing study.
Dressen A; Abbas AR; Cabanski C; Reeder J; Ramalingam TR; Neighbors M; Bhangale TR; Brauer MJ; Hunkapiller J; Reeder J; Mukhyala K; Cuenco K; Tom J; Cowgill A; Vogel J; Forrest WF; Collard HR; Wolters PJ; Kropski JA; Lancaster LH; Blackwell TS; Arron JR; Yaspan BL
Lancet Respir Med; 2018 Aug; 6(8):603-614. PubMed ID: 29891356
[TBL] [Abstract][Full Text] [Related]
16. Mucin 5B promoter polymorphism is associated with idiopathic pulmonary fibrosis but not with development of lung fibrosis in systemic sclerosis or sarcoidosis.
Stock CJ; Sato H; Fonseca C; Banya WA; Molyneaux PL; Adamali H; Russell AM; Denton CP; Abraham DJ; Hansell DM; Nicholson AG; Maher TM; Wells AU; Lindahl GE; Renzoni EA
Thorax; 2013 May; 68(5):436-41. PubMed ID: 23321605
[TBL] [Abstract][Full Text] [Related]
17.
Doubkova M; Kriegova E; Littnerova S; Schneiderova P; Sterclova M; Bartos V; Plackova M; Zurkova M; Bittenglova R; Lostaková V; Siskova L; Lisa P; Suldova H; Doubek M; Psikalova J; Snizek T; Musilova P; Vasakova M
Ther Adv Respir Dis; 2021; 15():17534666211042529. PubMed ID: 34515605
[TBL] [Abstract][Full Text] [Related]
18. The minor T allele of the MUC5B promoter rs35705950 associated with susceptibility to idiopathic pulmonary fibrosis: a meta-analysis.
Wu X; Li W; Luo Z; Chen Y
Sci Rep; 2021 Dec; 11(1):24007. PubMed ID: 34907291
[TBL] [Abstract][Full Text] [Related]
19. The relationship between complement C3 expression and the MUC5B genotype in pulmonary fibrosis.
Okamoto T; Mathai SK; Hennessy CE; Hancock LA; Walts AD; Stefanski AL; Brown KK; Lynch DA; Cosgrove GP; Groshong SD; Cool CD; Schwarz MI; Banda NK; Thurman JM; Yang IV; Holers VM; Schwartz DA
Am J Physiol Lung Cell Mol Physiol; 2018 Jul; 315(1):L1-L10. PubMed ID: 29565179
[TBL] [Abstract][Full Text] [Related]
20. The relationship between MUC5B promoter, TERT polymorphisms and telomere lengths with radiographic extent and survival in a Chinese IPF cohort.
Wang H; Zhuang Y; Peng H; Cao M; Li Y; Xu Q; Xin X; Zhou K; Liang G; Cai H; Dai J
Sci Rep; 2019 Oct; 9(1):15307. PubMed ID: 31653936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
